213 related articles for article (PubMed ID: 38602581)
1. Management of Oligometastatic and Locally Recurrent Urothelial Carcinoma.
Liu MA; Li JW; Runcie K
Curr Oncol Rep; 2024 May; 26(5):496-503. PubMed ID: 38602581
[TBL] [Abstract][Full Text] [Related]
2. Immunotherapy for Urothelial Carcinoma: Current Evidence and Future Directions.
Tripathi A; Plimack ER
Curr Urol Rep; 2018 Nov; 19(12):109. PubMed ID: 30406502
[TBL] [Abstract][Full Text] [Related]
3. The landscape of immunotherapy in metastatic urothelial carcinoma.
Teo MY; Iyer G
Curr Opin Urol; 2019 Nov; 29(6):643-648. PubMed ID: 31567441
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic strategies for upper tract urothelial carcinoma.
Freifeld Y; Krabbe LM; Clinton TN; Woldu SL; Margulis V
Expert Rev Anticancer Ther; 2018 Aug; 18(8):765-774. PubMed ID: 29848133
[TBL] [Abstract][Full Text] [Related]
5. Novel therapeutic targets in advanced urothelial carcinoma.
Rouanne M; Loriot Y; Lebret T; Soria JC
Crit Rev Oncol Hematol; 2016 Feb; 98():106-15. PubMed ID: 26589398
[TBL] [Abstract][Full Text] [Related]
6. Update of systemic immunotherapy for advanced urothelial carcinoma.
Gartrell BA; He T; Sharma J; Sonpavde G
Urol Oncol; 2017 Dec; 35(12):678-686. PubMed ID: 29079131
[TBL] [Abstract][Full Text] [Related]
7. [Immunotherapy in bladder cancer-quo vadis? Update on current trials and developments].
Todenhöfer T; Boegemann M
Urologe A; 2020 Jul; 59(7):810-816. PubMed ID: 32468092
[TBL] [Abstract][Full Text] [Related]
8. [Annular constriction of the rectum secondary to urothelial carcinoma of the bladder].
Ito Y; Nishimoto K; Ogata K; Fujioka T
Hinyokika Kiyo; 2008 Aug; 54(8):553-5. PubMed ID: 18788446
[TBL] [Abstract][Full Text] [Related]
9. [Immuno-oncological approaches in the perioperative therapy of muscle invasive bladder cancer].
Schmid SC; Koll FJ; Beckert F; Seitz AK
Urologe A; 2020 Jul; 59(7):790-796. PubMed ID: 32472221
[TBL] [Abstract][Full Text] [Related]
10. Molecular and histopathology directed therapy for advanced bladder cancer.
Alifrangis C; McGovern U; Freeman A; Powles T; Linch M
Nat Rev Urol; 2019 Aug; 16(8):465-483. PubMed ID: 31289379
[TBL] [Abstract][Full Text] [Related]
11. Advancements in the clinical management of upper tract urothelial carcinoma.
Taylor J; Meng X; Ghandour R; Margulis V
Expert Rev Anticancer Ther; 2019 Dec; 19(12):1051-1060. PubMed ID: 31770492
[No Abstract] [Full Text] [Related]
12. A new standard of care for advanced-stage urothelial carcinoma.
Sidaway P
Nat Rev Clin Oncol; 2024 May; 21(5):336. PubMed ID: 38509334
[No Abstract] [Full Text] [Related]
13. Metastatic urothelial cancer: evaluation of prognostic factors and change in prognosis during the last twenty years.
Sengeløv L; Kamby C; von der Maase H
Eur Urol; 2001 Jun; 39(6):634-42. PubMed ID: 11464051
[TBL] [Abstract][Full Text] [Related]
14. Letter to the editor for the article "Molecular urothelial tumor cell subtypes remain stable during metastatic evolution".
Song Y; Peng Y; Xu T
World J Urol; 2023 Oct; 41(10):2869-2870. PubMed ID: 37516671
[No Abstract] [Full Text] [Related]
15. Reasons for lack of treatment in patients with locally advanced, unresectable or metastatic urothelial carcinoma.
Omland LH; Joensen UN; Toft BG; Lund CM; Lindberg H; Knudsen MB; Tolver A; Suetta C; Pappot H
Acta Oncol; 2022 Sep; 61(9):1036-1042. PubMed ID: 36017555
[TBL] [Abstract][Full Text] [Related]
16. Perioperative Immunotherapy in Muscle-Invasive Bladder Cancer and Upper Tract Urothelial Carcinoma.
Teo MY; Rosenberg JE
Urol Clin North Am; 2018 May; 45(2):287-295. PubMed ID: 29650143
[TBL] [Abstract][Full Text] [Related]
17. Urothelial cancer of the urinary bladder: can lessons learned be applied to the upper urinary tract?
Krabbe LM; Hutchinson RC; Margulis V
Minerva Urol Nefrol; 2016 Aug; 68(4):396-408. PubMed ID: 26990295
[TBL] [Abstract][Full Text] [Related]
18. Difficult decisions in urologic oncology: management of high-grade T1 transitional cell carcinoma of the bladder.
Soloway MS; Lee CT; Steinberg GD; Ghandi AA; Jewett MA
Urol Oncol; 2007; 25(4):338-40. PubMed ID: 17628304
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of non-muscle-invasive bladder tumor history in patients with upper urinary tract urothelial carcinoma.
Milojevic B; Djokic M; Sipetic-Grujicic S; Grozdic Milojevic I; Vuksanovic A; Nikic P; Vukovic I; Djordjevic D; Bumbasirevic U; Tulic C
Urol Oncol; 2013 Nov; 31(8):1615-20. PubMed ID: 22521771
[TBL] [Abstract][Full Text] [Related]
20. [From marker expression to individual therapy of patients with bladder cancer].
Vom Dorp F; Börgermann C; Jäger T; Becker M; Schmid KW; Rübben H
Urologe A; 2008 Sep; 47(9):1167-70. PubMed ID: 18712513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
